{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:40:18Z","timestamp":1791571218162,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04104-6","type":"journal-article","created":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T22:33:20Z","timestamp":1751841200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Endobiliary radiofrequency ablation in recurrence and unresectable Perihilar cholangiocarcinoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Apiwat","family":"Jareanrat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasin","family":"Thanasukarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharatip","family":"Srisuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vor","family":"Luvira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theerawee","family":"Tipwaratorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anucha","family":"Ahooja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Watcharin","family":"Loilome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piya","family":"Prajumwongs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attapol","family":"Titapun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"issue":"5","key":"4104_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","volume":"13","author":"JM Banales","year":"2016","unstructured":"Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P, Lind GE, Folseraas T, Forbes SJ, Fouassier L, et al. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European network for the study of cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016;13(5):261\u201380.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"4104_CR2","first-page":"408","volume":"5","author":"JE Rogers","year":"2014","unstructured":"Rogers JE, Law L, Nguyen VD, Qiao W, Javle MM, Kaseb A, Shroff RT. Second-line systemic treatment for advanced cholangiocarcinoma. J Gastrointest Oncol. 2014;5(6):408\u201313.","journal-title":"J Gastrointest Oncol"},{"issue":"12","key":"4104_CR3","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/ajg.2014.327","volume":"109","author":"R Chaiteerakij","year":"2014","unstructured":"Chaiteerakij R, Harmsen WS, Marrero CR, Aboelsoud MM, Ndzengue A, Kaiya J, Therneau TM, Sanchez W, Gores GJ, Roberts LR. A new clinically based staging system for Perihilar cholangiocarcinoma. Am J Gastroenterol. 2014;109(12):1881\u201390.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"4104_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","volume":"234","author":"WR Jarnagin","year":"2001","unstructured":"Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ, Youssef BM, Klimstra D, Blumgart LH. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234(4):507\u201317. discussion 517\u2013\u2009509.","journal-title":"Ann Surg"},{"issue":"6","key":"4104_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00268-001-0291-1","volume":"26","author":"S Suzuki","year":"2002","unstructured":"Suzuki S, Sakaguchi T, Yokoi Y, Okamoto K, Kurachi K, Tsuchiya Y, Okumura T, Konno H, Baba S, Nakamura S. Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg. 2002;26(6):687\u201393.","journal-title":"World J Surg"},{"issue":"1","key":"4104_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.7314\/APJCP.2016.17.1.401","volume":"17","author":"V Luvira","year":"2016","unstructured":"Luvira V, Nilprapha K, Bhudhisawasdi V, Pugkhem A, Chamadol N, Kamsa-ard S. Cholangiocarcinoma patient outcome in Northeastern thailand: Single-Center prospective study. Asian Pac J Cancer Prev. 2016;17(1):401\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"4104_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2188\/jea.JE20180007","volume":"29","author":"S Kamsa-Ard","year":"2019","unstructured":"Kamsa-Ard S, Luvira V, Suwanrungruang K, Kamsa-Ard S, Luvira V, Santong C, Srisuk T, Pugkhem A, Bhudhisawasdi V, Pairojkul C. Cholangiocarcinoma trends, incidence, and relative survival in Khon kaen, Thailand from 1989 through 2013: A Population-Based Cancer registry study. J Epidemiol. 2019;29(5):197\u2013204.","journal-title":"J Epidemiol"},{"issue":"4","key":"4104_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1586\/14737140.2014.870480","volume":"14","author":"K Monkemuller","year":"2014","unstructured":"Monkemuller K, Popa D, Wilcox CM. Endoscopic treatment options for cholangiocarcinomas. Expert Rev Anticancer Ther. 2014;14(4):407\u201318.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"12","key":"4104_CR9","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1097\/MEG.0b013e3282f16206","volume":"19","author":"AC Moss","year":"2007","unstructured":"Moss AC, Morris E, Leyden J, MacMathuna P. Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction. Eur J Gastroenterol Hepatol. 2007;19(12):1119\u201324.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"4104_CR10","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.1016\/j.cgh.2020.12.020","volume":"20","author":"S Jang","year":"2022","unstructured":"Jang S, Stevens T, Parsi MA, Bhatt A, Kichler A, Vargo JJ. Superiority of Self-Expandable metallic stents over plastic stents in treatment of malignant distal biliary strictures. Clin Gastroenterol Hepatol. 2022;20(2):e182\u201395.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"4104_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/den.13680","volume":"33","author":"MX Xia","year":"2021","unstructured":"Xia MX, Pan YL, Cai XB, Wu J, Gao DJ, Ye X, Wang TT, Hu B. Comparison of endoscopic bilateral metal stent drainage with plastic stents in the palliation of unresectable hilar biliary malignant strictures: large multicenter study. Dig Endosc. 2021;33(1):179\u201389.","journal-title":"Dig Endosc"},{"issue":"1","key":"4104_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.gie.2010.09.031","volume":"73","author":"AW Steel","year":"2011","unstructured":"Steel AW, Postgate AJ, Khorsandi S, Nicholls J, Jiao L, Vlavianos P, Habib N, Westaby D. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc. 2011;73(1):149\u201353.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"4104_CR13","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.gie.2017.10.029","volume":"87","author":"AA Sofi","year":"2018","unstructured":"Sofi AA, Khan MA, Das A, Sachdev M, Khuder S, Nawras A, Lee W. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2018;87(4):944\u2013e951941.","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"4104_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/hep.22648","volume":"49","author":"YK Cho","year":"2009","unstructured":"Cho YK, Kim JK, Kim MY, Rhim H, Han JK. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology. 2009;49(2):453\u20139.","journal-title":"Hepatology"},{"issue":"6","key":"4104_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1159\/000184736","volume":"25","author":"S Mulier","year":"2008","unstructured":"Mulier S, Ruers T, Jamart J, Michel L, Marchal G, Ni Y. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update. Dig Surg. 2008;25(6):445\u201360.","journal-title":"Dig Surg"},{"key":"4104_CR16","first-page":"12","volume":"06No","author":"H Liang","year":"2015","unstructured":"Liang H, Peng Z, Cao L, Qian S, Shao Z. Metal stenting with or without endobiliary radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma. J Cancer Therapy. 2015;06No:11:12.","journal-title":"J Cancer Therapy"},{"issue":"6","key":"4104_CR17","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.gie.2020.04.075","volume":"92","author":"J Yang","year":"2020","unstructured":"Yang J, Wang J, Zhou H, Wang Y, Huang H, Jin H, Lou Q, Shah RJ, Zhang X. Endoscopic radiofrequency ablation plus a novel oral 5-fluorouracil compound versus radiofrequency ablation alone for unresectable extrahepatic cholangiocarcinoma. Gastrointest Endosc. 2020;92(6):1204\u201312. e1201.","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"4104_CR18","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s00464-013-3232-9","volume":"28","author":"W Dolak","year":"2014","unstructured":"Dolak W, Schreiber F, Schwaighofer H, Gschwantler M, Plieschnegger W, Ziachehabi A, Mayer A, Kramer L, Kopecky A, Schrutka-Kolbl C, et al. Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications. Surg Endosc. 2014;28(3):854\u201360.","journal-title":"Surg Endosc"},{"issue":"12","key":"4104_CR19","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1007\/s10620-014-3264-6","volume":"59","author":"RZ Sharaiha","year":"2014","unstructured":"Sharaiha RZ, Natov N, Glockenberg KS, Widmer J, Gaidhane M, Kahaleh M. Comparison of metal stenting with radiofrequency ablation versus stenting alone for treating malignant biliary strictures: is there an added benefit? Dig Dis Sci. 2014;59(12):3099\u2013102.","journal-title":"Dig Dis Sci"},{"key":"4104_CR20","doi-asserted-by":"publisher","first-page":"109830","DOI":"10.1016\/j.ejrad.2021.109830","volume":"142","author":"T Andrasina","year":"2021","unstructured":"Andrasina T, Rohan T, Panek J, Kovalcikova P, Kunovsky L, Ostrizkova L, Valek V. The combination of endoluminal radiofrequency ablation and metal stent implantation for the treatment of malignant biliary stenosis - Randomized study. Eur J Radiol. 2021;142:109830.","journal-title":"Eur J Radiol"},{"issue":"6","key":"4104_CR21","doi-asserted-by":"publisher","first-page":"AB91","DOI":"10.1016\/j.gie.2019.04.081","volume":"89","author":"R Buerlein","year":"2019","unstructured":"Buerlein R, Strand DS, Patrie JT, Sauer BG, Shami VM, Scheiman JM, Zaydfudim VM, Bauer TW, Adams RB, Wang AY. 544 ercp-directed biliary ablation prolongs survival in patients with unresectable Perihilar cholangiocarcinoma compared to stenting alone. Gastrointest Endosc. 2019;89(6):AB91\u20132.","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"4104_CR22","first-page":"853","volume":"33","author":"W Cui","year":"2017","unstructured":"Cui W, Wang Y, Fan W, Lu M, Zhang Y, Yao W, Li J. Comparison of intraluminal radiofrequency ablation and stents vs. stents alone in the management of malignant biliary obstruction. Int J Hyperth. 2017;33(7):853\u201361.","journal-title":"Int J Hyperth"},{"issue":"9305","key":"4104_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0140-6736(02)07683-3","volume":"359","author":"KF Schulz","year":"2002","unstructured":"Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance, not choice. Lancet. 2002;359(9305):515\u20139.","journal-title":"Lancet"},{"issue":"1","key":"4104_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ijerph8010015","volume":"8","author":"J Efird","year":"2011","unstructured":"Efird J. Blocked randomization with randomly selected block sizes. Int J Environ Res Public Health. 2011;8(1):15\u201320.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"4104_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg"},{"issue":"2","key":"4104_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.gie.2016.09.037","volume":"85","author":"W-C Liao","year":"2017","unstructured":"Liao W-C, Angsuwatcharakon P, Isayama H, Dhir V, Devereaux B, Khor CJL, Ponnudurai R, Lakhtakia S, Lee D-K, et al. International consensus recommendations for difficult biliary access. Gastrointest Endosc. 2017;85(2):295\u2013304.","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"4104_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0016-5107(91)70740-2","volume":"37","author":"PB Cotton","year":"1991","unstructured":"Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RCG, Meyers WC, Liguory C, Nickl N. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37(3):383\u201393.","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"4104_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gie.2016.06.051","volume":"85","author":"V Chandrasekhara","year":"2017","unstructured":"Chandrasekhara V, Khashab MA, Muthusamy VR, Acosta RD, Agrawal D, Bruining DH, Eloubeidi MA, Fanelli RD, Faulx AL, Gurudu SR, et al. Adverse events associated with ERCP. Gastrointest Endosc. 2017;85(1):32\u201347.","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"4104_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/jhbp.512","volume":"25","author":"S Kiriyama","year":"2018","unstructured":"Kiriyama S, Kozaka K, Takada T, Strasberg SM, Pitt HA, Gabata T, Hata J, Liau K-H, Miura F, Horiguchi A, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):17\u201330.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"4104_CR30","doi-asserted-by":"publisher","first-page":"893252","DOI":"10.3389\/fmed.2022.893252","volume":"9","author":"C Aphivatanasiri","year":"2022","unstructured":"Aphivatanasiri C, Sa-Ngiamwibool P, Sangkhamanon S, Intarawichian P, Kunprom W, Thanee M, Prajumwongs P, Khuntikeo N, Titapun A, Jareanrat A, et al. Modification of the eighth AJCC\/UICC staging system for Perihilar cholangiocarcinoma: an alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand. Front Med (Lausanne). 2022;9:893252.","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"4104_CR31","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.hpb.2017.07.004","volume":"19","author":"MP Gaspersz","year":"2017","unstructured":"Gaspersz MP, Buettner S, van Vugt JLA, Roos E, Coelen RJS, Vugts J, Belt EJ, de Jonge J, Polak WG, Willemssen F, et al. Conditional survival in patients with unresectable Perihilar cholangiocarcinoma. HPB (Oxford). 2017;19(11):966\u201371.","journal-title":"HPB (Oxford)"},{"issue":"6","key":"4104_CR32","first-page":"2747","volume":"33","author":"C Mosconi","year":"2013","unstructured":"Mosconi C, Renzulli M, Giampalma E, Galuppi A, Balacchi C, Brandi G, Ercolani G, Bianchi G, Golfieri R. Unresectable Perihilar cholangiocarcinoma: multimodal palliative treatment. Anticancer Res. 2013;33(6):2747\u201353.","journal-title":"Anticancer Res"},{"issue":"1","key":"4104_CR33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10585-022-10193-4","volume":"40","author":"CLA Dewald","year":"2022","unstructured":"Dewald CLA, Becker LS, Meine TC, Maschke SK, Wacker FK, Saborowski A, Vogel A, Hinrichs JB. New perspectives in unresectable cholangiocarcinoma? Evaluation of chemosaturation with percutaneous hepatic perfusion as a palliative treatment option. Clin Exp Metastasis. 2022;40(1):95\u2013104.","journal-title":"Clin Exp Metastasis"},{"key":"4104_CR34","doi-asserted-by":"publisher","unstructured":"Park Y, Won D-S, Bae G-H, Ryu DS, Kang JM, Kim JW, Kim SH, Zeng CH, Park W, Lee SS, et al. Silver Nanofunctionalized Stent after Radiofrequency Ablation Suppresses Tissue Hyperplasia and Bacterial Growth. Pharmaceutics. 2022;14(2):412. https:\/\/doi.org\/10.3390\/pharmaceutics14020412.","DOI":"10.3390\/pharmaceutics14020412"},{"issue":"7","key":"4104_CR35","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1055\/a-1133-4448","volume":"52","author":"T Inoue","year":"2020","unstructured":"Inoue T, Ibusuki M, Kitano R, Kobayashi Y, Ohashi T, Nakade Y, Sumida Y, Ito K, Yoneda M. Endobiliary radiofrequency ablation combined with bilateral metal stent placement for malignant hilar biliary obstruction. Endoscopy. 2020;52(7):595\u20139.","journal-title":"Endoscopy"},{"issue":"4","key":"4104_CR36","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1499-3872(13)60066-1","volume":"12","author":"H Alis","year":"2013","unstructured":"Alis H, Sengoz C, Gonenc M, Kalayci MU, Kocatas A. Endobiliary radiofrequency ablation for malignant biliary obstruction. Hepatobiliary Pancreat Dis Int. 2013;12(4):423\u20137.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"4104_CR37","doi-asserted-by":"publisher","first-page":"13685","DOI":"10.1038\/s41598-019-50132-0","volume":"9","author":"A Bokemeyer","year":"2019","unstructured":"Bokemeyer A, Matern P, Bettenworth D, Cordes F, Nowacki TM, Heinzow H, Kabar I, Schmidt H, Ullerich H, Lenze F. Endoscopic radiofrequency ablation prolongs survival of patients with unresectable hilar cholangiocellular Carcinoma - A Case-Control study. Sci Rep. 2019;9(1):13685.","journal-title":"Sci Rep"},{"issue":"5","key":"4104_CR38","doi-asserted-by":"publisher","first-page":"877","DOI":"10.5009\/gnl240032","volume":"18","author":"K Yang","year":"2024","unstructured":"Yang K, Yang H, Kim CW, Nam HC, Kim JH, Lee A, Chang UI, Yang JM, Lee HL, Kwon JH, et al. Effect of biliary drainage on the prognosis of patients with hepatocellular carcinoma and bile duct invasion. Gut Liver. 2024;18(5):877\u201387.","journal-title":"Gut Liver"},{"issue":"11","key":"4104_CR39","first-page":"939","volume":"12","author":"MM Ram\u00edrez-Mej\u00eda","year":"2024","unstructured":"Ram\u00edrez-Mej\u00eda MM, Castillo-Casta\u00f1eda SM, Pal SC, Qi X, M\u00e9ndez-S\u00e1nchez NJJC, Hepatology T. The Multifaceted Role of Bilirubin in Liver Disease: A Literature Review. J Clin Transl Hepatol. 2024;12(11):939\u201348.","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"4104_CR40","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1038\/s41598-025-86443-8","volume":"15","author":"T Rohan","year":"2025","unstructured":"Rohan T, Cechova B, Matkulcik P, Straka M, Zavadil J, Eid M, Uher M, Dostal M, Andrasina T. Prognostic factors for survival in patients with advanced cholangiocarcinoma treated with percutaneous transhepatic drainage. Sci Rep. 2025;15(1):2172.","journal-title":"Sci Rep"},{"issue":"1","key":"4104_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12876-025-03596-6","volume":"25","author":"M Omouri-Kharashtomi","year":"2025","unstructured":"Omouri-Kharashtomi M, Alemohammad SY, Moazed N, Afzali Nezhad I, Ghoshouni H. Prognostic value of albumin-bilirubin grade in patients with cholangiocarcinoma: a systematic review and meta-analysis. BMC Gastroenterol. 2025;25(1):19.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"4104_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/cld.861","volume":"15","author":"JYL Chiang","year":"2020","unstructured":"Chiang JYL, Ferrell JM. Bile Acid Biology, Pathophysiology, and Therapeutics. Clin Liver Dis (Hoboken). 2020;15(3):91\u20134.","journal-title":"Clin Liver Dis (Hoboken)"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04104-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04104-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04104-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:02:53Z","timestamp":1751846573000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04104-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4104"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04104-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5948371\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was performed based on the Declaration of Helsinki and approved by the Human Research Ethics Committee, Khon Kaen University (HE611487). Before the samples were collected, informed and written consent was obtained from all patients. In addition, this study has been registered with the Thai Clinical Trials Registry (TCTR) under the registration number TCTR20190704002, on 04 June 2019.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"501"}}